| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
134,770,000 |
| Market
Cap: |
18.54(B) |
| Last
Volume: |
676,634 |
Avg
Vol: |
1,177,221 |
| 52
Week Range: |
$120.62 - $144.92 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 724 |
| Guru Rank Value : 1.3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
16,337 |
16,337 |
16,337 |
534,469 |
| Total Sell Value |
$2,062,619 |
$2,062,619 |
$2,062,619 |
$75,079,355 |
| Total People Sold |
3 |
3 |
3 |
6 |
| Total Sell Transactions |
6 |
6 |
6 |
24 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rusckowski Stephen H |
Chairman, CEO and President |
• • – |
2022-05-23 |
4 |
OE |
$86.63 |
$7,302,052 |
D/D |
77,466 |
377,401 |
|
- |
|
| Morrison Denise M |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,292 |
6,540 |
|
- |
|
| Doi Tracey |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,292 |
2,209 |
|
- |
|
| Main Timothy L |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,292 |
22,243 |
|
- |
|
| Ring Timothy M |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,292 |
23,933 |
|
- |
|
| Pfeiffer Gary M |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,292 |
24,982 |
|
- |
|
| Lassiter Wright Iii |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,292 |
4,633 |
|
- |
|
| Gregg Vicky B |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,292 |
16,922 |
|
- |
|
| Wilensky Gail R |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,292 |
19,137 |
|
- |
|
| Deppe Michael J |
VP, Corp. Controller & CAO |
• – – |
2022-05-18 |
4 |
D |
$136.98 |
$1,096 |
D/D |
(8) |
32,006 |
|
- |
|
| Prevoznik Michael E |
SVP & General Counsel |
• – – |
2022-05-17 |
4 |
S |
$139.97 |
$7,082,991 |
D/D |
(50,604) |
39,224 |
|
13% |
|
| Prevoznik Michael E |
SVP & General Counsel |
• – – |
2022-05-17 |
4 |
OE |
$66.51 |
$3,365,672 |
D/D |
50,604 |
89,828 |
|
- |
|
| Gregg Vicky B |
Director |
– • – |
2022-04-18 |
4 |
A |
$134.88 |
$8,228 |
D/D |
61 |
15,630 |
|
- |
|
| Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
• – – |
2022-03-08 |
4 |
AS |
$135.21 |
$950,797 |
D/D |
(7,032) |
67,733 |
|
-0% |
|
| Prevoznik Michael E |
SVP & General Counsel |
• – – |
2022-03-08 |
4 |
AS |
$135.21 |
$842,088 |
D/D |
(6,228) |
39,224 |
|
-0% |
|
| Deppe Michael J |
VP, Corp. Controller & CAO |
• – – |
2022-03-07 |
4 |
D |
$130.09 |
$118,902 |
D/D |
(914) |
32,011 |
|
- |
|
| Deppe Michael J |
VP, Corp. Controller & CAO |
• – – |
2022-03-07 |
4 |
A |
$130.09 |
$327,306 |
D/D |
2,516 |
32,089 |
|
- |
|
| Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
• – – |
2022-03-07 |
4 |
D |
$130.09 |
$827,372 |
D/D |
(6,360) |
74,765 |
|
- |
|
| Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
• – – |
2022-03-07 |
4 |
A |
$130.09 |
$1,742,165 |
D/D |
13,392 |
81,125 |
|
- |
|
| Guinan Mark |
Executive Vice President & CFO |
• – – |
2022-03-07 |
4 |
D |
$130.09 |
$1,362,693 |
D/D |
(10,475) |
98,981 |
|
- |
|
| Guinan Mark |
Executive Vice President & CFO |
• – – |
2022-03-07 |
4 |
A |
$130.09 |
$2,703,270 |
D/D |
20,780 |
109,456 |
|
- |
|
| Prevoznik Michael E |
SVP & General Counsel |
• – – |
2022-03-07 |
4 |
D |
$130.09 |
$691,558 |
D/D |
(5,316) |
45,452 |
|
- |
|
| Prevoznik Michael E |
SVP & General Counsel |
• – – |
2022-03-07 |
4 |
A |
$130.09 |
$1,501,759 |
D/D |
11,544 |
50,768 |
|
- |
|
| Rusckowski Stephen H |
Chairman, CEO and President |
• • – |
2022-03-07 |
4 |
D |
$130.09 |
$4,237,031 |
D/D |
(32,570) |
334,833 |
|
- |
|
| Rusckowski Stephen H |
Chairman, CEO and President |
• • – |
2022-03-07 |
4 |
A |
$130.09 |
$9,130,237 |
D/D |
70,184 |
367,403 |
|
- |
|
787 Records found
|
|
Page 7 of 32 |
|
|
0.63 (0.46%) 
